GLP-1 Prescription Medication Delivered to your doorstep

Doctor prescribed Tirzepatide & Semaglutide.
No medical insurance required.


See if I qualify

GLP-1 medications have been featured in

Begin your weight loss journey
in 3 easy steps

1

Get Qualified

Fill out our online medical intake questionnaire, with your health and weight loss goals. Our doctors will review your information to see if you qualify.

2

Meet with Doctor

Schedule a free telehealth appointment with one of our licensed doctors, who will discuss the different weight loss medication options available to you.

3

Receive Medication

Receive your GLP-1 prescribed weight loss medication in the mail every month. Free shipping directly to your door.

GLP-1 medications Mounjaro® (Tirzepatide) and Ozempic® (Semaglutide), are the most effective weight loss medications currently available - that's why they're so popular!

Are you tired of trying various weight loss diets without seeing lasting results? At FMC we've designed a comprehensive weight loss program that addresses the biological factors involved in sustainable weight loss. With our scientifically backed approach, you can achieve the weight loss success you've been striving for - for good.

How much weight can I expect to lose?

In clinical studies of Tirzepatide, the FDA approved active ingredient in Mounjaro® and Zepbound®, patients achieved 21.1% weight loss during a 36-week lead-in period and an additional 6.7% weight loss during a 52-week continued treatment period, for a total mean weight loss of 27.8% over 88 weeks. This equates to a weight loss of 55.6 pounds for a 200 pound person.

Losing significant weight over time has been shown to result in continued weight loss, reduced risk for weight regain, and successful long-term weight loss maintenance.

Join Now

Frequently Asked Questions


To begin your FMC journey, simply complete our quick online medical intake form. Your responses are private and reviewed by our clinical team. During your first telehealth visit, your provider will confirm your eligibility and recommend the GLP-1 medication that best aligns with your weight-loss goals. One form. One appointment. A completely personalized treatment plan.

Tirzepatide and Semaglutide are FDA-approved active ingredients used in Mounjaro®, Zepbound®, Ozempic®, and Wegovy®, which have helped millions of people lose and maintain weight.


Medically approved patients are typically prescribed Tirzepatide or Semaglutide injections, which are slowly absorbed by the body over a week’s duration to help curb appetite and reduce cravings.


The Tirzepatide or Semaglutide GLP-1 medication you may be prescribed is a compounded generic medication and is not associated with the pharmaceutical companies Eli Lilly™ or Novo Nordisk™, nor their brand-name medications Mounjaro®, Zepbound®, Ozempic®, or Wegovy®.

Mounjaro® & Zepbound® (Tirzepatide) work differently than other drugs in the GLP-1 family, as they contain an extra molecule that may give them a slight edge. These medications mimic two incretin hormones (GLP-1 and GIP), affecting appetite and satiety.


Ozempic® & Wegovy® (Semaglutide) regulate food intake and appetite by acting as human GLP-1 receptor agonists. They suppress appetite, control cravings, and help you feel full longer by slowing stomach emptying.


When combined with diet and exercise, GLP-1 medications can lead to significant weight loss and reduce risks of diabetes, cancer, and heart disease in overweight individuals.

GLP-1 microdosing involves using smaller, carefully adjusted doses of your prescribed medication rather than following standard dosing alone. At FMC, microdosing is an option offered by our providers when clinically appropriate. Your provider determines the dosing schedule, which may include weekly injections or smaller amounts given more frequently.

This approach is designed to help maintain more consistent medication levels in the body, which can reduce common side effects such as nausea while still supporting appetite control and steady weight management. Many patients find that microdosing improves comfort and makes treatment easier to maintain over time.

Microdosing is a clinical strategy used by some healthcare professionals and is not part of FDA-approved dosing guidelines. Your FMC provider will help determine whether this personalized approach is right for you.

Our program is not eligible for coverage through health-insurance providers. Participants pay directly via ACH transfer, credit, or debit card — ensuring flexible and convenient access to their health journey.

Our subscription plans vary based on duration and provide significant savings compared to retail prices — Mounjaro®, Zepbound®, Ozempic®, and Wegovy® average $1,300–$1,500 per month. FMC offers the same active ingredients for a fraction of the cost while including consultations, prescriptions, and shipping.


For complete pricing on our subscription weight-loss plans, CLICK HERE.

Yes. The telehealth consultation, prescription, GLP-1 medication, and shipment are all included in your subscription — no hidden fees.

Your shipment will arrive promptly after our clinicians review your monthly progress and issue the next prescription, ensuring you always have medication on hand to continue your journey.

A monthly follow-up telehealth appointment is required to discuss your progress with your clinician. They’ll adjust your GLP-1 medication — Semaglutide (Ozempic®, Wegovy®) or Tirzepatide (Mounjaro®, Zepbound®) — as needed to optimize your results.